In Vitro Protein Expression Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global in vitro protein expression market is set to experience substantial growth, reaching a significant value by the conclusion of the assessment period. Over the years 2019-2023, the market witnessed notable expansion, and this trajectory is projected to continue with a value CAGR of 8.0% through the forecast period, surpassing US$ 240 Mn in 2024.
Driving Factors
The growth of the in vitro protein expression market can be attributed to several factors. Increasing demand for continuous-exchange in vitro protein synthesis, coupled with rising consumption of in vitro protein systems in bio-pharma and biotech companies, is fueling market expansion. Moreover, the demand for simple and effective protein production methods, along with technological advancements, further propels market growth.
Research and Development Initiatives
Strong research and development initiatives associated with in vitro protein synthesis have significantly expanded the adoption of in vitro protein expression systems. These systems find increased utilization in various applications, including protein library generation for customized drug development, functional genomic studies, and the expression of virus-like particles, among others. Additionally, in vitro protein expressions serve as potential tools in genetic diagnostics and can be used alongside truncated proteins for mutation detection in marker genes.
Market Segmentation
Within the market, the E.coli system segment holds a major share. Widely used due to its cost-effectiveness and higher protein yield, the E.coli system segment is anticipated to continue its dominance. It is estimated to expand at a remarkable CAGR of 7.1% throughout the assessment period, reaching a market valuation just under US$ 115 Mn in 2024.
The mammalian system segment, while the second-largest, is expected to contribute significantly to market growth, with a high rate of expansion anticipated during the forecast period.
In contrast, the insect cells system and wheat germ system segments are comparatively lower in valuation but poised to register moderate CAGR during the forecast period. Of these, the wheat germ system segment holds a relatively larger share compared to the insect cells system segment.
Regional Insights
In North America, particularly the United States, the in vitro protein expression market is witnessing rapid adoption, with E.coli and mammalian systems leading the growth. The mammalian system segment is expected to experience higher demand in the coming years, with a stellar CAGR projected during the forecast period. Similarly, the E.coli system segment in North America is expected to register a robust CAGR of 5.8% during the forecast period.
Competitive Analysis
Key companies functioning in the global in vitro protein expression market including:
• Thermo Fisher Scientific, Inc.
• Takara Bio Company
• New England Biolabs
• Promega Corporation
• Jena Bioscience GmbH
• GeneCopoeia, Inc.
• Biotechrabbit GmbH
• Cube Biotech GmbH
• CellFree Sciences Co., Ltd.
• Bioneer Corporation
• Others.
Market Segmentation
Product Type
• coli System
• Rabbit Reticulocytes System
• Wheat Germ System
• Insect Cells System
• Mammalian System
Expression Mode
• Continuous Flow Expression
• Batch Expression
End User
• Biotechnological Companies
• Pharmaceutical Companies
• Contract Research Organizations
• Academic and Research Institutes
Application
• Enzyme Engineering
• Protein Labeling
• Protein-Protein Interaction
• Protein Purification
Region
• North America
• Latin America
• Europe
• Asia Pacific
• MEA
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.